Login / Signup

Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial.

Ethel Leslie CiampiReinaldo Uribe-San-MartinClaudia CárcamoJuan Pablo CruzAna ReyesDiego ReyesCarmen PintoMacarena VásquezRafael A BurgosJuan Hancke
Published in: BMC neurology (2020)
ClinicalTrials.gov NCT02273635 retrospectively registered on October 24th, 2014.
Keyphrases
  • double blind
  • multiple sclerosis
  • placebo controlled
  • clinical trial
  • phase iii
  • white matter
  • phase ii
  • study protocol
  • randomized controlled trial